SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue for the quarter ended June 2025 remained nearly unchanged at Rs. 14941.70 millions.Net Profit of the company move down -41.25% to Rs. 1035.20  millions from Rs. 1761.90 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 2215.30 millions from 2945.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 14941.70 14755.60 1.26 14941.70 14755.60 1.26 60326.30 58740.60 2.70
Other Income 77.90 31.40 148.09 77.90 31.40 148.09 478.90 313.20 52.91
PBIDT 2215.30 2945.70 -24.80 2215.30 2945.70 -24.80 9492.70 10298.40 -7.82
Interest 226.40 126.90 78.41 226.40 126.90 78.41 764.70 544.70 40.39
PBDT 1988.90 2818.80 -29.44 1988.90 2818.80 -29.44 8856.70 9753.70 -9.20
Depreciation 733.70 686.80 6.83 733.70 686.80 6.83 2770.80 2711.40 2.19
PBT 1255.20 2132.00 -41.13 1255.20 2132.00 -41.13 6085.90 7042.30 -13.58
TAX 220.00 370.10 -40.56 220.00 370.10 -40.56 1054.70 377.50 179.39
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1035.20 1761.90 -41.25 1035.20 1761.90 -41.25 5031.20 6664.80 -24.51
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 14.83 19.96 -25.73 14.83 19.96 -25.73 15.74 17.53 -10.25

Alembic Pharma Share Price

752.30 -17.50 (-2.27%)
24-Apr-2026 15:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.50
Dr. Reddys Lab 1315.50
Cipla 1295.85
Zydus Lifesciences 926.65
Lupin 2295.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×